You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TIMI flow

Showing 1 - 25 of 8,575
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Addiction and Acute Coronary Syndrome

Not yet recruiting
  • Acute Coronary Syndrome
  • Addiction
  • speckle tracking echocardiography
  • Percutaneous coronary intervention
  • (no location specified)
Oct 28, 2022

No-Reflow Phenomenon, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Nicorandil, Placebo)

Not yet recruiting
  • No-Reflow Phenomenon
  • +2 more
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 16, 2022

MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated

Withdrawn
  • STEMI - ST Elevation Myocardial Infarction
  • (no location specified)
Feb 1, 2023

Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)

Active, not recruiting
  • Coronary Microvascular Dysfunction
  • Beijing, Beijing, China
    Peking university first hospital
Aug 1, 2023

STEMI, Primary PCI Trial in Wuhan (Heparin Sodium Injection)

Recruiting
  • STEMI
  • Primary PCI
  • Heparin Sodium Injection
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan university
Jul 29, 2022

Coronary Artery Disease, Coronary Bifurcation Lesion Trial in Eindhoven (Hybrid DEB approach with drug-eluting balloon,

Not yet recruiting
  • Coronary Artery Disease
  • Coronary Bifurcation Lesion
  • Hybrid DEB approach with drug-eluting balloon
  • Two-stent strategy
  • Eindhoven, North- Brabant, Netherlands
    Catharina Hospital
Feb 7, 2023

Coronary Microvascular Obstruction in PCI

Recruiting
  • Myocardial Infarction
  • No-Reflow Phenomenon
  • different variants of SNPs that may be associated with the coronary microvascular obstruction development
  • Nizhny Novgorod, Nizhny Novgorod Region, Russian Federation
  • +1 more
Nov 18, 2022

STEMI, Large Thrombus Burden, No-Reflow Phenomenon Trial (Upfront preparation of microcirculation to minimize risks of no-reflow

Not yet recruiting
  • STEMI
  • +2 more
  • Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
  • (no location specified)
May 26, 2022

Coronary Artery Disease Trial (Percutaneous coronary intervention)

Not yet recruiting
  • Coronary Artery Disease
  • Percutaneous coronary intervention
  • (no location specified)
Jun 26, 2023

Characterize REAL-WORLD EVIDENCE Regarding Safety and

Not yet recruiting
  • Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts
    • (no location specified)
    Sep 7, 2022

    STEMI - ST Elevation Myocardial Infarction, Inferior Wall Myocardial Infarction Trial in Worldwide (PiCSO Impulse System)

    Recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Inferior Wall Myocardial Infarction
    • PiCSO Impulse System
    • Aarhus, Denmark
    • +10 more
    Apr 5, 2022

    Coronary Artery Disease Trial in Sion, Lausanne, Geneva (Balloon dilatation)

    Completed
    • Coronary Artery Disease
    • Balloon dilatation
    • Sion, Valis, Switzerland
    • +2 more
    Jan 23, 2023

    Coronary Arteriosclerosis Trial in Hangzhou, Shanghai (OrbusNeich Scoreflex TRIO, OrbusNeich Scoreflex NC)

    Recruiting
    • Coronary Arteriosclerosis
    • OrbusNeich Scoreflex TRIO
    • OrbusNeich Scoreflex NC
    • Hangzhou, Zhejiang, China
    • +3 more
    Jun 23, 2023

    Coronary Stenosis Trial in Canada, United States (Ringer Perfusion Balloon Catheter)

    Recruiting
    • Coronary Stenosis
    • Ringer Perfusion Balloon Catheter
    • Torrance, California
    • +6 more
    Feb 2, 2023

    Outcomes After PCI of the Aneurysmatic Right Coronary Artery

    Recruiting
    • Coronary Disease
    • +4 more
    • Percutaneous Coronary Intervention
    • Bergamo, Italy
    • +7 more
    Feb 1, 2023

    Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional

    Recruiting
    • Coronary Artery Disease
    • Ischemic Heart Disease
    • Procedure: planed 2-stent strategy
    • Procedure: provisional 1-stent plus DEB strategy
    • Suwon, Gyeonggi-do, Korea, Republic of
      St. Vincent's Hospital , the Catholic University
    Aug 17, 2023

    ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

    Not yet recruiting
    • ST Elevation Myocardial Infarction (STEMI)
    • Rosuvastatin 20 mg
    • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
    • (no location specified)
    Feb 1, 2023

    Coronary Artery Disease Trial (Simple Crossover, Side branch opening)

    Not yet recruiting
    • Coronary Artery Disease
    • Simple Crossover
    • Side branch opening
    • (no location specified)
    Jan 26, 2023

    ST-segment Elevation Myocardial Infarction (STEMI), Total Occlusion of Coronary Artery, Primary Percutaneous Coronary

    Not yet recruiting
    • ST-segment Elevation Myocardial Infarction (STEMI)
    • +2 more
    • Export Catheter
    • Balloon catheter
    • (no location specified)
    Aug 19, 2022

    STEMI Trial in Cairo (Dapagliflozin)

    Recruiting
    • STEMI
    • Cairo, Egypt
      Helwan University
    Jul 16, 2023

    Cardiovascular Diseases Trial in Peking (cardiomyopeptidin)

    Active, not recruiting
    • Cardiovascular Diseases
    • Peking, Beijing, China
      Chinese People's Liberation Army General Hospital
    Dec 1, 2023

    Intravascular ULTRAsound-Guided PCI in ST-Elevation Myocardial

    Not yet recruiting
    • STEMI
    • +2 more
    • IVUS imaging for primary PCI guidance
    • (no location specified)
    Jul 25, 2023

    The FLUYDO NC Post Market Clinical Follow-up Study

    Completed
    • Coronary Artery Disease
    • +2 more
    • FLUYDO NC percutaneous transluminal coronary angioplasty balloon catheter
    • Istanbul, Turkey
      Alvimedica
    Jul 19, 2023

    The INVADER™ Percutaneous Transluminal Coronary Angioplasty Post

    Completed
    • Coronary Artery Disease
    • +2 more
    • INVADER™ PTCA Balloon Dilatation Catheter
    • Istanbul, Turkey
      Alvimedica
    Jun 13, 2023

    Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™

    Active, not recruiting
    • Ischemic Heart Disease
    • +4 more
    • Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
    • Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
    • Shenyang, Liaoning, China
    • +1 more
    Nov 2, 2022